Oxford Randomized Study Shows Budesonide Effectiveness for Outpatient Treatment
The results of the so called STOIC clinical trial run by Oxford University and testing budesonide have just been published as a pre-print on medrxiv.
The results of the so called STOIC clinical trial run by Oxford University and testing budesonide have just been published as a pre-print on medrxiv.
In France, like in the USA, Canada and most European countries, hydroxychloroquine has attracted huge controversy and its reputation as a drug for COVID-19 has
In this second part of our interview with Professor Christian Perronne, MD, PhD, from France, we cover the questions of clinical trials and therapy approval
Since mid-March, early treatments were known to have great potential as a cure for COVID-19. Dr Zelenko was already treating his patients in NY State
“This is your Darkest Hour, Boris: let’s have some real leadership. Without that, God help us all.” While the #OxfordGate #RecoveryGate #CovidPapers story is still
At a media conference this Tuesday, COVID-19 survivor and UK prime minister Boris Johnson announced “the biggest breakthrough yet” regarding therapies for the coronavirus. THIS
“Dexamethasone is the first drug to be shown to improve survival in COVID-19. This is an extremely welcome result,” said Peter Horby, Professor of Emerging Infectious
This article, published (in English and French) in the leading online French newspaper France Soir, asserts that the UK therapeutic approach to COVID-19 is flawed,
Little noticed was an announcement on May 27 by the Oxford RECOVERY trial that Remdesivir was now available for those participating in the trial, encompassing
While the hydroxychloroquine arm of the RECOVERY Randomized Clinical Trial was terminated last Friday, the research continues to make waves in the French media, seemingly
There is a video on YouTube showing how to seek consent from volunteer patients to participate in the RECOVERY trial. The video, which serves as
In a video interview today, Professor Didier Raoult, from IHU-Marseille, blasts the Oxford academics having carried out the RECOVERY randomized controlled trials having tested hydroxychloroquine